Militia Capital Partners LP Reduces Stock Position in iShares Biotechnology ETF $IBB

Militia Capital Partners LP cut its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 34.5% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 10,800 shares of the financial services provider’s stock after selling 5,700 shares during the quarter. Militia Capital Partners LP’s holdings in iShares Biotechnology ETF were worth $1,823,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Potomac Fund Management Inc. ADV acquired a new position in shares of iShares Biotechnology ETF in the 4th quarter worth approximately $13,799,000. Portfolio Resources Advisor Group Inc. acquired a new position in shares of iShares Biotechnology ETF in the 4th quarter worth approximately $163,000. Sargent Investment Group LLC acquired a new position in shares of iShares Biotechnology ETF in the 4th quarter worth approximately $245,000. MML Investors Services LLC grew its position in shares of iShares Biotechnology ETF by 72.7% in the 4th quarter. MML Investors Services LLC now owns 114,683 shares of the financial services provider’s stock worth $19,355,000 after acquiring an additional 48,289 shares in the last quarter. Finally, Mariner LLC grew its position in shares of iShares Biotechnology ETF by 20.9% in the 4th quarter. Mariner LLC now owns 38,900 shares of the financial services provider’s stock worth $6,565,000 after acquiring an additional 6,719 shares in the last quarter. 62.45% of the stock is currently owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Trading Down 0.4%

Shares of IBB opened at $171.44 on Wednesday. The stock has a 50 day moving average of $170.38 and a 200-day moving average of $170.64. iShares Biotechnology ETF has a 52 week low of $123.61 and a 52 week high of $179.64.

iShares Biotechnology ETF Cuts Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, June 18th. Stockholders of record on Monday, June 15th will be given a $0.0238 dividend. The ex-dividend date is Monday, June 15th. This represents a $0.10 annualized dividend and a dividend yield of 0.1%.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.